ADvantage Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$13.7M
- Investors
-
1
ADvantage Therapeutics General Information
Description
Operator of a pharmaceutical company intended to develop therapeutics for patients suffering from neurodegenerative disease. The company specializes in developing therapies to treat Alzheimer's Disease and potentially paradigm-changing therapies, enabling healthcare professionals to better treat neurodegenerative conditions.
Contact Information
Website
www.advantagetherapeutics.comCorporate Office
- 195 Northwest 40th Street
- Miami, FL 33127
- United States
Corporate Office
- 195 Northwest 40th Street
- Miami, FL 33127
- United States
ADvantage Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 28-Jul-2025 | $13.7M | Completed | Clinical Trials - Phase 2 | ||
| 1. Seed Round | 24-Jun-2021 | Completed | Startup |
ADvantage Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
ADvantage Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ADvantage Therapeutics Patents
ADvantage Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4566618-A1 | Nucleic acid encoding klotho for use in therapeutic and non-therapeutic methods for reducing body weight | Inactive | 06-Dec-2023 | ||
| EP-4773989-A1 | Nucleic acid encoding klotho for use in therapeutic and non-therapeutic methods for reducing body weight | Pending | 22-Nov-2023 | ||
| WO-2025109173-A1 | Nucleic acid encoding klotho for use in therapeutic and non-therapeutic methods for reducing body weight | Inactive | 22-Nov-2023 | ||
| AU-2024238978-A1 | Klotho mrna | Pending | 22-Mar-2023 | ||
| EP-4434534-A1 | Klotho mrna | Pending | 22-Mar-2023 | A61P43/00 |
ADvantage Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ADvantage Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| quadraScope Ventures | Venture Capital | Minority |
ADvantage Therapeutics Investments (2)
ADvantage Therapeutics’s most recent deal was a Early Stage VC with Recapp (Movies, Music and Entertainment) for . The deal was made on 03-Feb-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Recapp (Movies, Music and Entertainment) | 03-Feb-2026 | Early Stage VC | Movies, Music and Entertainment | ||
| Klogenix (Intellectual Property Asset Portfolio) | 02-Oct-2023 | Corporate Asset Purchase | Buildings and Property |
ADvantage Therapeutics FAQs
-
When was ADvantage Therapeutics founded?
ADvantage Therapeutics was founded in 2021.
-
Where is ADvantage Therapeutics headquartered?
ADvantage Therapeutics is headquartered in Miami, FL.
-
What is the size of ADvantage Therapeutics?
ADvantage Therapeutics has 13 total employees.
-
What industry is ADvantage Therapeutics in?
ADvantage Therapeutics’s primary industry is Drug Discovery.
-
Is ADvantage Therapeutics a private or public company?
ADvantage Therapeutics is a Private company.
-
What is the current valuation of ADvantage Therapeutics?
The current valuation of ADvantage Therapeutics is .
-
What is ADvantage Therapeutics’s current revenue?
The current revenue for ADvantage Therapeutics is .
-
How much funding has ADvantage Therapeutics raised over time?
ADvantage Therapeutics has raised $18.7M.
-
Who are ADvantage Therapeutics’s investors?
quadraScope Ventures has invested in ADvantage Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
